SQM Sociedad Química y Minera de Chile S.A.
Initiation Report
Comprehensive investment thesis with rating, target price, sector analysis, valuation, and risk assessment.
Rating
SELL
Target
$57.00
Upside
(35.7%)
Thesis
SQM trades at a substantial premium to fair value implied by mid-cycle DCF assum...
INITIATING COVERAGE
SQM — Sociedad Quimica y Minera de Chile S.A.
Basic Materials — Specialty Chemicals (Lithium, Iodine, SPN, Potassium, Industrial Chemicals)
RATING SELL | TARGET PRICE $57.00 | UPSIDE / (DOWNSIDE) (35.7%) |
Current Price: $88.70 (NYSE) | Conviction: Moderate | 2026-04-28
Agentic Finance Chile — Produced via Agentic AI Workflow
Executive Summary
We initiate coverage of Sociedad Quimica y Minera de Chile S.A. (NYSE: SQM) with a SELL rating and a 12-month target price of $57.00 per share, implying (35.7%) downside from the current $88.70 close. Our target is anchored to a DCF base case of $57.18 (rounded down to $57.00 per coverage policy — no rounding up), at WACC 9.85% and exit EV/EBITDA 9.0x. The rating is the output of the valuation framework, not a preselected view: SQM trades at $88.70 already pricing in a near-bull-case lithium recovery and a fully NPV-accretive Codelco JV — a combination of outcomes we view as plausible but not assured.
The market embeds three simultaneous positive outcomes in today's price: (1) faster lithium recovery (>12% volume CAGR vs our base 9.4%), (2) higher terminal multiples (~11x EV/EBITDA vs our base 9x), and (3) accretive Codelco JV economics. Each is plausible standalone, but joint probability is modest. Our scenario range is wide ($28.95 Bear / $57.18 Base / $88.90 Bull). Notably the Bull case approximates the current price — meaning the upside is largely priced in, while downside paths are unpriced. Conviction is Moderate (not High) because the Bull case is intellectually defensible if all three vectors converge.
Key thesis pillars: (1) valuation runs ahead of fundamentals (18.5x P/E, 11x EV/EBITDA vs lithium-cycle median ~9-10x); (2) Codelco JV unlocks reserve life but compresses near-term cash-flow share; (3) lithium S&D balance still vulnerable through 2027 with only mild deficit 2028-2030; (4) iodine and SPN provide defense (~$600M EBITDA) but cannot alone justify >$50/share; (5) structural risks include Chilean political risk, currency exposure, technology disruption tail, and capex intensity through 2027.
Summary Table
Item | 2025A / Current | 2030E / Target |
Share Price | $88.70 | $57.00 (TP) |
Market Cap | $25.3B | $16.3B (@ TP) |
Revenue | $5,150M | $7,420M |
EBITDA | $1,520M (29.5% mg) | $2,600M (35.0% mg) |
Net Income | $815M | $1,420M |
P/E NTM | 18.5x | ~11.5x (target) |
EV/EBITDA NTM | 11.0x | 9.0x (exit) |
Dividend Yield (50% payout) | ~1.6% | ~3.0% (@ TP) |
Investment Thesis — Five Pillars
Pillar 1: Valuation Runs Ahead of Fundamentals
SQM trades at 18.5x 2025 P/E and 11x 2026E EV/EBITDA — a meaningful premium to lithium-cycle median EV/EBITDA of ~9-10x and to current pure-play peer median of ~7x (Albemarle, Arcadium, Pilbara, Ganfeng). The 2025 rally (+30% YTD into Apr 2026) discounted a recovery scenario that requires three things to converge simultaneously: lithium prices to stabilize >$15k/ton, the Codelco JV to be NPV-accretive at terms not yet final, and iodine prices to hold at $55+/kg in a market still adjusting to post-pandemic contrast media demand normalization.
Each leg is plausible standalone. Lithium spot has recovered to $13-15k/ton from the late-2024 lows of $9-10k. Codelco-SQM negotiations remain constructive. Iodine prices have held above $50/kg through 2025-2026. But joint probability of all three landing in the bull configuration is, by our estimation, no more than 25-30%. The current price discounts something close to 100% probability of all three. We see asymmetric downside if any one of the three disappoints — and there are credible disappointment paths for each.
Multiple math: at our base 2027E EBITDA of $1,840M and a 9x exit multiple (consistent with cycle median), implied EV is $16.6B. Subtracting net debt (~$2.0B normalized) gives equity of $14.6B or ~$51/share. Add Codelco JV uplift of ~$5/share already announced, and base equity value lands near $56-57. The market price of $88.70 implicitly applies an 11x multiple AND a higher EBITDA — a combination that requires both cycle re-rating and bull volume/price.
Pillar 2: Codelco JV — Reserve Life Win, Near-Term Cash Flow Compression
The 2024 Codelco-SQM agreement extends Salar de Atacama lithium operations to 2060 (vs the original Corfo lease expiration in 2030), securing reserve life and resolving the existential overhang from the Boric administration's 2023 nationalization push. This is a meaningful win for SQM — without it, Atacama lithium production faced a hard 2030 stop. The JV structure, however, is 50/50 through 2030 transitioning to Codelco majority post-2030, which reduces SQM's economic share of cash flows from ~85% historically (after Corfo lease/royalty) to ~50% post-2030.
Net NPV impact is positive but modest in equity terms. We estimate $4-6/share NPV uplift from the additional 30 years of operations net of the cash-flow share dilution and increased royalty effective burden. This uplift is already in the share price — the announcement-day pop of ~12% on Dec-2024 implies the market priced in $7-8/share at peak optimism, leaving little incremental upside as terms get formalized.
Risks to the JV thesis: (a) final terms (still being formalized through 2026) could be less accretive than the announcement framework; (b) royalty effective rate could rise via new mining royalty legislation (pending in Chilean Congress through 2026-2027); (c) operational integration with Codelco (a state-owned copper producer with no lithium experience) creates execution risk through 2030 transition. None of these are central paths, but each is asymmetric to the downside vs current pricing.
Pillar 3: Lithium S&D Balance Still Vulnerable Through 2027
Despite the 2025 price recovery, lithium supply-side response remains rapid and elastic. Australian lepidolite (mothballed 2024) is ramping back at $11-12k/ton economics; Chinese converter capacity is ample (>2.4MT LCE/yr nameplate); Argentine projects (Allkem/POSCO Sal de Vida and Olaroz expansion, Eramet Centenario-Ratones, Lithium Americas Cauchari-Olaroz Stage 2) are ramping in 2026-2028 with combined incremental ~150-200kt LCE/yr. We model surplus persistence through 2027 (~80kt LCE annual surplus) and only mild deficit of 30-50kt 2028-2030.
Our base-case lithium price assumption is $13-14k/ton 2026, $14-15k/ton 2027-2028, $15-16k/ton terminal — consistent with cycle median pricing and roughly the cost of marginal supply (Chinese lepidolite + DLE pilot economics). This is already the modal forecast across sell-side coverage; the SQM share price embeds a more bullish $17-19k/ton terminal price, reading the supply discipline scenario as central.
Demand outlook: EV growth remains the central driver. Global EV penetration of new vehicles 22% (2025) → 35% (2030) → 50%+ (2035), per BNEF and IEA STEPS. Stationary storage adds ~150-200kt LCE/yr by 2030. We model lithium demand CAGR of 18% through 2030. The supply-side response is what matters more than demand at the margin, given the latter is well-modeled.
Pillar 4: Iodine and SPN Provide Defense But Not Full Offset
SQM is the global #1 iodine producer at ~30% market share, with structurally attractive economics: iodine EBITDA margins are ~55-60% (vs lithium's volatile 20-50% range). Iodine demand grows ~3-4% annually driven by X-ray contrast media (~30% of demand), LCD displays (~15%), pharmaceutical intermediates, biocides, and specialty chemicals. Pricing has held at $50-60/kg through the lithium downcycle, generating ~$600M EBITDA at peak — roughly 40% of SQM's total EBITDA in the trough lithium environment of 2024.
SPN (Specialty Plant Nutrition) is the #1 global producer of nitrate-based specialty fertilizers, generating ~$300-350M EBITDA at 25-30% margins. SPN demand grows 4-5% annually with high-value horticultural crops. Combined iodine + SPN provide ~$900M EBITDA floor — a defensive base.
The math, however, doesn't support the current price on the defensive segments alone. At 9x EV/EBITDA on $900M iodine+SPN EBITDA, implied EV from these segments is $8.1B, or ~$28/share equity. Lithium must contribute the remaining ~$60/share for the current price to make sense — implying lithium EBITDA of $1.7-1.9B at 9x or $1.5-1.7B at 11x. This requires bull-case lithium volumes AND prices, which is the core skeptical pillar of our thesis. Even peak iodine + SPN cannot justify >$50/share alone.
Pillar 5: Structural Risks Provide Asymmetric Downside
Chilean political risk: the 2026 presidential election (Nov 2025) installed a center-right administration but Congress remains divided. Pending legislation includes mining royalty reform (Senate consideration through 2026), water rights tightening at the Salar de Atacama, and indigenous (Atacameños) consultation rules under ILO Convention 169. None are existential, but each carries 1-3% margin or NPV impact downside.
Currency exposure: revenue largely USD; cost base is CLP (~40%), USD (~30%), RMB and EUR (~30%). CLP appreciation vs USD compresses margins; SQM has historically managed via partial hedging but residual translation impact remains. Sensitivity: ~150bps EBITDA margin per 10% CLP appreciation.
Lithium technology disruption: sodium-ion batteries and DLE represent multi-year tail risks (detailed in Disruptive Threat Assessment section). Neither displaces lithium materially in the 5-year window, but probability-weighted impact on terminal value is non-trivial. Capex intensity: at ~11% of revenue near-term ($550-600M annual capex), FCF generation remains constrained through 2027 and supports our cautious near-term cash-flow base.
Company Overview
Sociedad Quimica y Minera de Chile S.A. (SQM) is a Chilean specialty chemicals producer founded in 1968 (privatized 1988), headquartered in Santiago, listed on NYSE (ADR) and Bolsa de Comercio de Santiago. SQM is the world's #1 iodine producer, the #2 lithium producer (post-Albemarle), the #1 specialty plant nutrient producer, and a meaningful potassium producer. The company's Salar de Atacama operation is one of the world's lowest-cost lithium brine assets, with grandfathered Corfo lease terms (now extended to 2060 via the Codelco JV).
Strategic positioning: SQM's competitive advantage rests on (1) Atacama brine resource quality (1,800-2,200 ppm Li, vs 200-1,000 ppm for emerging projects); (2) integrated nitrate-iodine extraction in the Tarapaca and Antofagasta regions; (3) low-cost solar evaporation; (4) downstream conversion capacity at Salar del Carmen (lithium carbonate + hydroxide). Combined cash cost position is in the lowest decile of the lithium cost curve.
Revenue by Segment (2025E)
Segment | 2025E Revenue | % of Total | EBITDA Margin | Key Commentary |
Lithium | $2,420M | 47% | 32% | Atacama brine + Carmen conversion; #2 globally |
Iodine & Derivatives | $1,030M | 20% | 58% | #1 globally; ~30% market share; defensive |
Specialty Plant Nutrition | $1,090M | 21% | 28% | #1 nitrate-based specialty fertilizer |
Potassium (KCl, K2SO4) | $330M | 6% | 18% | Atacama by-product; commodity exposure |
Industrial Chemicals | $280M | 6% | 22% | Solar salts, nitrate derivatives |
TOTAL | $5,150M | 100% | 29.5% | — |
Key Operations
Salar de Atacama (Antofagasta Region): SQM's flagship lithium and potassium asset. Brine evaporation ponds + downstream pipeline to Salar del Carmen for conversion. ~210kt LCE/yr nameplate; ~180kt actual 2025 production. Among the lowest-cost lithium operations globally (cash cost ~$4-5k/ton LCE).
Salar del Carmen (Antofagasta Region): Lithium carbonate and lithium hydroxide conversion plant. Capacity ~210kt LCE/yr (post-2024 expansion). Both battery-grade and technical-grade output. Conversion margins typically 35-45% on input brine.
Coya Sur, Pedro de Valdivia, Maria Elena, Nueva Victoria (Tarapaca / Antofagasta): Caliche ore mining and iodine + nitrate extraction. Combined ~13-14kt iodine/yr (#1 globally). Co-production of sodium nitrate and potassium nitrate for SPN segment. Old-line operations with continuous capex maintenance ($150-200M/yr).
Mt. Holland (Western Australia): JV with Wesfarmers. Spodumene + downstream lithium hydroxide conversion. Phase 1 ramping 2025-2026, ~50kt LCE/yr SQM share at full ramp. Diversifies brine concentration risk; higher cost (~$8-10k/ton) than Atacama but provides Western Hemisphere supply story.
Management & Governance
CEO Ricardo Ramos (since 2018): Chilean engineer, internal promote (ex-CFO 2007-2018). Long-tenured operator, deep Atacama expertise. Led the strategic pivot toward lithium expansion 2018-2024 and the Codelco JV negotiation. Conservative communicator, focus on operational discipline.
CFO Gerardo Illanes (since 2018): Internal promote, prior treasury and IR roles. Manages capital allocation, debt structure, dividend policy (50% payout target). Credited for navigating the 2024 trough liquidity stress without dilutive financing.
Board ownership structure: Pampa Group (Julio Ponce Lerou family) ~25% (largest shareholder via Pampa Calichera); Tianqi Lithium (Chinese strategic) ~22% (acquired 2018, controversial then-deal); Public float ~50%. Pampa-Tianqi co-existence creates a complex governance dynamic; minority protection has been a concern historically (related-party concerns 2016-2018 settled with Chilean SVS in 2019).
Capital structure: 285.6M total shares (143M Series A — 1 vote each; 142.6M Series B — 1/3 vote each). Voting concentration is bimodal between Pampa and Tianqi. Total debt $4.76B, cash $2.72B, net debt $2.04B. Investment-grade rated (S&P BBB / Moody's Baa2), though Codelco JV transition introduces rating watch in 2026-2027.
Sector Analysis
Lithium — Battery Chemistry Cycle
The lithium market is in the second year of a price recovery from the late-2024 trough ($9-10k/ton spot LCE). Spot has recovered to $13-15k/ton through Q1 2026 driven by (a) Chinese stimulus and EV credit extension, (b) Australian high-cost mine closures clearing surplus, (c) inventory drawdown post-2023 destocking. Demand growth remains structurally robust (EV penetration 22% → 35%+ by 2030; stationary storage emerging). Supply, however, is rapidly elastic — the cycle could be shorter than the 2017-2020 cycle if discipline breaks.
Cost curve: SQM and Albemarle Atacama brine sit at ~$4-5k/ton cash cost (lowest decile). Australian spodumene at $7-9k/ton. Chinese lepidolite at $10-13k/ton (marginal supply). Hardrock-to-hydroxide pathways carry $2-3k/ton conversion cost on top. The marginal cost of supply at $13-15k/ton supports current pricing but is vulnerable if Chinese lepidolite ramps faster than expected.
Demand by application (2025): EVs ~58% (rising to ~70% by 2030), stationary energy storage ~12% (rising to ~18%), portable electronics ~7%, industrial/other ~23%. The EV-driven demand acceleration narrative is unambiguous; the question is whether supply discipline holds vs an oversupply repeat.
Geographic supply concentration: Australia (~46% of global supply), Chile (~24%), China (~16%), Argentina (~6%), Other (~8%). Chile's share is forecast to decline to ~20% by 2030 as Australian and Argentine projects ramp — reducing SQM's relative supply influence and pricing power.
Iodine — Stable Oligopoly
Iodine is a structurally attractive market: ~36kt/yr global demand, growing 3-4% annually; oligopoly supply (SQM 30%, Cosayach 20%, ACF 10%, Japanese 25%, others 15%); high barriers to entry (caliche-ore deposits geologically constrained to Atacama Desert and Japan brine). Price volatility is moderate — 2014-2018 saw $20-30/kg trough on Chinese demand softness; 2020-2024 recovery to $50-60/kg sustained. Demand drivers: contrast media (3% growth), LCD displays (2-3%), pharmaceuticals (4-5%), biocides (~5%).
Supply discipline has been a defining feature of the iodine industry. Japanese producers (Ise Chemical, Kanto Natural Gas) operate at production caps to support pricing. Chilean producers face ore-grade depletion at older operations, requiring continuous capex to maintain volumes. New supply entry is geologically constrained and capex-intensive (5-7 year project timelines).
Pricing outlook: We model iodine prices in the $52-58/kg range through 2030, reflecting (a) steady demand growth, (b) supply discipline, (c) modest cost inflation. This generates ~$600-700M annual EBITDA for SQM at peak — a defensive base independent of lithium cycle dynamics. Iodine is the single most underappreciated value driver in SQM's portfolio.
SPN — Specialty Premium
Specialty plant nutrition (nitrate-based fertilizers) commands a 30-50% pricing premium vs commodity NPK. End markets: high-value crops (vegetables, fruits, ornamentals) where the premium product economics are justified by yield/quality. Demand grows 4-5% annually, faster than commodity fertilizer (1-2%). SQM is #1 globally with ~25% share; Yara is #2.
Pricing dynamics: SPN average selling prices have held in $850-950/ton range through 2024-2026, supported by tight nitrate supply and structurally inelastic demand from high-value horticultural buyers. Margin profile is stable at 25-30% EBITDA — defensive baseline. Volume growth driven by expansion in protected agriculture (Mexico, Spain, Morocco), drip-irrigation systems, and crop quality premium markets in EU/US.
Potassium — Commodity By-product
Potassium chloride (MOP) and sulphate of potash (SOP) are extracted as by-products of the Atacama brine evaporation cycle. Volumes ~1.0-1.2 Mt annually; average selling prices $280-350/ton through 2024-2026. Margin profile is the lowest in SQM's portfolio (~18% EBITDA) reflecting commodity pricing and competition from Belarussian/Russian potash. Strategic role is brine value-chain optimization (capturing every salt component) rather than standalone profit center.
Outlook: potash prices have stabilized post-2022 Belarus disruption normalization. We model flat-to-modest growth (1-2% volume CAGR, flat real pricing). Not a thesis driver but provides ~$60M annual EBITDA contribution at marginal economics.
Industrial Chemicals — Niche Defensive
Industrial chemicals (solar salts, sodium nitrate derivatives, specialty industrial nitrates) generate ~$280M revenue at 22% EBITDA margins. Solar salts are used as thermal storage in concentrated solar power (CSP) plants — niche but growing as CSP gains traction in MENA and Spain. Sodium nitrate finds use in glass manufacturing, metallurgy, explosives. Demand growth 3-4% annually. Defensive but small contributor.
Financial Analysis
Historical Financial Performance (2023-2025)
Metric (USD M) | 2023A | 2024A | 2025A | CAGR 23-25 |
Revenue | $7,468 | $4,500 | $5,150 | -17.0% |
Revenue Growth | -21% | -40% | +14% | Trough/recovery |
Gross Profit | $3,800 | $1,520 | $1,920 | -29% |
Gross Margin | 50.9% | 33.8% | 37.3% | -1360bps |
EBITDA | $3,250 | $1,180 | $1,520 | -32% |
EBITDA Margin | 43.5% | 26.2% | 29.5% | -1400bps |
EBIT | $2,860 | $820 | $1,140 | -37% |
Net Income | $2,015 | $510 | $815 | -36% |
EPS (USD) | $7.06 | $1.79 | $2.85 | — |
FCF | $2,200 | $420 | $650 | -46% |
Capex | $1,000 | $760 | $590 | -23% |
Net Debt / EBITDA | 0.4x | 1.6x | 1.3x | — |
Note: 2023 was the lithium peak; 2024 the trough. Recovery into 2025 driven by lithium price stabilization, iodine pricing strength, and SPN volume growth. EBITDA margin recovered to 29.5% (still well below 2022-2023 peak of 50%+). Balance sheet remained investment-grade through trough.
Forward Projections (2026-2030E)
Metric (USD M) | 2026E | 2027E | 2028E | 2029E | 2030E |
Revenue | $5,580 | $6,030 | $6,540 | $7,000 | $7,420 |
Growth % | +8% | +8% | +8% | +7% | +6% |
EBITDA | $1,720 | $1,840 | $2,090 | $2,350 | $2,600 |
EBITDA Margin | 30.8% | 30.5% | 32.0% | 33.6% | 35.0% |
Net Income | $925 | $1,000 | $1,150 | $1,290 | $1,420 |
FCF | $780 | $880 | $1,080 | $1,260 | $1,420 |
Capex | $610 | $590 | $540 | $520 | $510 |
EPS (USD) | $3.24 | $3.50 | $4.03 | $4.52 | $4.97 |
Capital deployment: SQM has historically run a 50% dividend payout ratio. We model this continuing through 2030, supplemented by selective M&A or organic capacity (Mt. Holland Phase 2, potential Argentine project). No buyback program currently active. Balance sheet target ~1x net debt/EBITDA through cycle.
Capital Deployment & Dividend Policy
Dividend policy: 50% of prior-year net income, paid quarterly. 2025 dividend ~$1.43/share (based on 2024 trough net income); 2026 expected ~$1.40/share rising to ~$2.50/share by 2030 as earnings recover. At our $57 target, implied yield is ~3.0% — defensive but not premium for the operational risk profile.
Capex profile: $760M (2024 peak) declining to $510M by 2030 as Atacama expansion completes and Mt. Holland matures. Capex/revenue normalizes from ~17% (2024) to ~7% (2030). Maintenance capex ~$300-350M annually; growth capex tapering. Cumulative 2026-2030 capex: ~$2.8B, comfortably funded from operating cash flow without incremental debt.
M&A optionality: SQM has historically prioritized organic growth over M&A. Recent transactions (Mt. Holland JV with Wesfarmers 2018, Codelco JV 2024) are partnership structures rather than control acquisitions. We do not model accretive M&A in our forecast.
Balance Sheet Strength
Net debt: $2.04B (Q4 2025), debt $4.76B less cash $2.72B. Net debt/EBITDA 1.3x — comfortable investment-grade range. S&P BBB / Moody's Baa2 ratings stable. Debt maturity profile is well-laddered: $400-600M annual maturities through 2030, weighted average duration 5.2 years, weighted average coupon 4.8%. No covenant pressure. Liquidity strong: $2.72B cash + $1.5B undrawn revolver = $4.2B available liquidity.
Refinancing risk: $850M maturity in 2027 will refinance at higher coupon (estimated 5.5-6.0%) given rate environment, adding ~$8-12M annual interest expense. Manageable but signal of cycle-end higher cost of capital.
Valuation
Comparable Companies Analysis
SQM trades at a premium to the pure-play lithium peer set. Median peer NTM EV/EBITDA is 7.2x, 75th percentile 8.5x — vs SQM's 11.0x. The premium has historically been justified by (a) Atacama cost-curve position, (b) iodine and SPN diversification (no peer has comparable integrated portfolio), (c) Codelco JV catalyst. We acknowledge the premium is justifiable but argue current multiple overshoots the appropriate level.
Peer | EV/EBITDA NTM | P/E NTM | EBITDA Margin | Comment |
Albemarle (ALB) | 8.0x | 16x | 18% | Direct lithium peer |
Arcadium (ALTM) | 6.5x | 14x | 22% | Pre-Rio Tinto bid level |
Pilbara Minerals (PLS.AX) | 7.0x | 12x | 28% | Pure-play hardrock |
Ganfeng (1772.HK) | 6.8x | 11x | 16% | Vertically integrated China |
Median Peers | 7.2x | 13x | 21% | — |
75th Percentile | 8.5x | 16x | 28% | — |
SQM (current) | 11.0x | 18.5x | 29.5% | Premium to all |
SQM (target $57) | 9.0x | 16x | 30.5% | Premium normalized |
DCF — Base Case Target $57.18
Our DCF base case yields fair value of $57.18 per share, rounded down per coverage policy to $57.00 target price. Inputs: WACC 9.85% (CAPM-based: Rf 4.25%, beta 1.18, ERP 5.5%, Chile country risk premium 1.0% — Chile sovereign EMBI spread normalized; Ke 11.74%, Kd 5.8% after-tax, target 30% debt/total cap); terminal growth 2.5% (consistent with global GDP/inflation); exit EV/EBITDA 9.0x (cycle median, applied to 2030 EBITDA of $2,600M).
Scenario | Lithium Price | WACC | Implied Price | Upside/(Down) |
Bear | $10-12k/ton | 11.0% | $28.95 | (67.4%) |
Base (Primary) | $14-16k/ton | 9.85% | $57.18 | (35.5%) |
Bull | $18-20k/ton | 8.5% | $88.90 | +0.2% |
Target Price (Base, rounded) | — | — | $57.00 | (35.7%) |
Critical observation: the Bull case implied price ($88.90) approximates today's market price ($88.70). The market is currently pricing the Bull case at near 100% probability — no margin of safety, with downside paths (Bear → Base) representing material drawdown risk. Our 35.7% downside target reflects the central-path scenario, with significant tail risk to Bear ($28-29) on lithium price decline below $12k/ton.
WACC × Terminal Growth Sensitivity
WACC \ g | 1.5% | 2.0% | 2.5% (Base) | 3.0% |
8.85% | $59.20 | $63.40 | $68.50 | $74.80 |
9.35% | $54.30 | $57.80 | $61.90 | $66.80 |
9.85% (Base) | $50.20 | $53.20 | $57.18 | $61.20 |
10.35% | $46.70 | $49.20 | $52.40 | $56.10 |
10.85% | $43.60 | $45.80 | $48.50 | $51.60 |
Bridge to Current Price
To justify the current $88.70 price, the market must believe: (1) terminal exit multiple of 11x (vs our 9x) — adds ~$15/share; (2) terminal lithium price of $18-19k/ton (vs $14-16k base) — adds ~$10/share; (3) Codelco JV NPV at upper end of disclosed framework — adds ~$3-4/share; (4) faster volume CAGR (12%+ vs base 9.4%) — adds ~$3-4/share. Sum = ~$31-32/share above our base case, bridging to ~$88-89. Each component is plausible; the joint probability is the question. Our assessment: ~25-30% joint probability — meaningfully below the ~95-100% the market currently embeds.
Competitive Landscape & Disruptive Threat Assessment
Per coverage policy, we explicitly evaluate each material disruptive threat to SQM's lithium franchise with scale, S-curve trajectory, evidence, trigger events, and SQM's positioning. Lithium-substitution threats are real but operate on multi-year tail-risk timelines. Each is rigorously assessed below.
Threat 1: Sodium-Ion Batteries
- Current scale: <2% of cell production globally (2025). CATL launched commercial deployment in 2024 in BYD ESS systems and entry-level EV models; HiNa Battery and BYD operate dedicated production lines.
- S-curve trajectory: Deployment accelerating but constrained by ~5% energy density discount vs LFP and 3000+ cycle life only recently achieved. Cost per kWh competitive at iron-rich raw material prices but lithium price recovery has narrowed the cost advantage from 2024.
- Why manageable for SQM (5-10 year window): SPN/iodine cushion provides ~$900M EBITDA defensive base independent of lithium chemistry. Lithium demand still growing 18%+ CAGR through 2030 even with sodium-ion eating share at the low end. Sodium-ion will compete first in stationary storage and short-range applications, not displacing lithium in mainstream EVs (where energy density matters). Material lithium displacement requires energy density gap to close to <10% AND cost advantage to widen >30%.
- Trigger events: (1) sodium-ion ESS share exceeding 25% (currently <8%); (2) a Tier 1 EV OEM committing to sodium-ion for >300 mile range vehicles; (3) sodium-ion cost gap vs LFP widening to >25%.
- SQM positioning: Limited optionality as a pure lithium player. Mitigant: lithium carbonate (SQM's primary product) is used in LFP cathodes, which are gaining share against nickel-rich (NMC/NCA) chemistries. So the LFP-vs-NMC mix shift is FAVORABLE for SQM specifically vs hydroxide-focused producers. Sodium-ion would compete with LFP at the low end — moderate not catastrophic for SQM.
Threat 2: Direct Lithium Extraction (DLE)
- Current scale: Pilot scale only. BHE Salton Sea ~2-5kt LCE/yr capacity (operating); ExxonMobil Smackover ~10kt LCE/yr (expected commercial 2027); Eramet Argentina (~2.5kt LCE 2026 ramp). Combined commercial DLE <5kt LCE/yr in 2025, rising to perhaps 25-40kt by 2028.
- S-curve trajectory: Multiple technology paths (adsorption, ion-exchange, membranes) with lab data suggesting 90%+ recovery (vs ~50% for traditional evaporation). Potentially 12-18 month project timeline (vs 5-7 yr for new salar). However, scale economics not yet proven; capex per tonne advantage of Atacama brine evaporation persists.
- Why manageable for SQM (3-5 year window): Atacama brine cost curve position remains lowest decile. SQM's grandfathered contract terms (now Codelco JV) still favorable. DLE economics at scale (>10ktpa) not yet proven. Capex per tonne advantage of brine evaporation persists. SQM has been investing in DLE pilot at Salar de Atacama (Aristas project, announced 2024) — strategic hedge but lagging best-in-class technology developers.
- Trigger events: (1) a DLE project demonstrates <$8k/ton all-in cash cost at >10kt LCE/yr scale; (2) Smackover or Salton Sea reaches commercial operation with margin > brine equivalent; (3) a major OEM (Tesla, GM, Ford) backs a DLE-sourced supply chain over brine.
- SQM positioning: Defensive but lagging on technology. The Aristas pilot is a strategic insurance policy. If DLE reaches commercial scale at <$8k/ton, SQM's brine cost advantage erodes from 60% premium to 20-30% — still profitable but multiple compression follows.
Threat 3: LFP Cathodes (NEUTRAL/POSITIVE for SQM)
- Current scale: ~70% of China EVs and ~25% of US EVs (rising) as of Q1 2026. LFP share has grown from <30% in 2020 to ~50%+ globally.
- Why this is not a threat to SQM: LFP cathodes require lithium CARBONATE (SQM's primary product) — whereas nickel-rich (NMC, NCA) cathodes require lithium HYDROXIDE. As LFP gains share, demand mix tilts toward carbonate, which FAVORS SQM relative to hydroxide-focused producers (e.g., legacy Livent, Albemarle's Talison conversion).
- Trigger events that would make this a threat: (1) a third cathode chemistry (sodium-ion or solid-state lithium-metal anode) replacing LFP entirely; (2) a hydroxide-favoring chemistry breakthrough (unlikely given current trajectory).
- SQM positioning: Aligned. SQM's carbonate-heavy mix (~75% carbonate, ~25% hydroxide) is a competitive advantage in the LFP-dominant world.
Threat 4: Lithium Recycling
- Current scale: <2% of lithium supply 2025. Expected 5-10% by 2030; longer-term 20-30% by 2040. Major players: Redwood Materials (~10kt LCE recycling capacity 2025), Li-Cycle (~3kt), Ascend Elements, Aqua Metals.
- Why manageable: Recycling is supply-augmenting; the price effect is modest in the next 5 years given total demand growth (1.5MT → ~3MT LCE by 2030 — recycling adds at most 10% supplement). Beyond 2030, recycling becomes a more meaningful supply source as the first generation of EV batteries reaches end-of-life.
- Trigger events: (1) Tesla / OEMs reaching mandated 30%+ recycled content (EU 2031 regulation already in place but not yet binding); (2) Redwood/Li-Cycle reaching commercial scale at margin parity with virgin supply; (3) China establishing aggressive recycled-content rules.
- SQM positioning: Limited. SQM has not invested in recycling capacity to date. Long-term, this is an offensive opportunity (closed-loop with OEMs) but currently not material.
Overall Disruption Conclusion
None of the four threats individually is sufficient to disrupt SQM's lithium franchise within a 5-year window. The combination of (a) sodium-ion at the low end + (b) DLE at the cost-curve middle + (c) recycling on the supply side could compress lithium prices structurally by 2030-2032, eroding the margin assumption embedded in our long-dated DCF. Our base-case terminal lithium price of $14-16k/ton already reflects this combined pressure conservatively. The Bull case ($88+/share) requires this combined pressure to NOT materialize — another reason why current pricing is asymmetrically negative.
Risks
Lithium Price Decline Below $10k/ton (HIGH impact, MODERATE probability)
Primary downside risk. Triggered by (a) Australian lepidolite ramping faster than expected, (b) Argentine project schedule acceleration, (c) Chinese stimulus reversing/EV slowdown, (d) macro recession compressing EV demand. Each is plausible. Our Bear case assumes $10-12k/ton, implying $28.95 fair value (-67% from current). Probability: 30-35% over 12-18 months.
Codelco JV Terms Less Accretive Than Market Expects (HIGH, MODERATE)
Final Codelco-SQM JV terms (operational details, royalty structure, capex sharing) are still being formalized through 2026. Market embeds a benign outcome. If terms include (a) higher royalty effective rate, (b) larger Codelco operational control, or (c) capex burden skew toward SQM, NPV uplift could compress to $1-2/share (vs $4-6 base). Trigger: Codelco JV formal agreement (expected Q3 2026 - Q1 2027). Probability of negative surprise: 30-40%.
Chile Mining Royalty Reform (MODERATE, MODERATE)
Chilean Congress is considering mining royalty changes through 2026. Current copper royalty (1-14% sliding scale) was reformed in 2023; lithium-specific reform pending. Worst case: 5-10% incremental royalty on lithium revenue, compressing EBITDA margin by 200-400bps. Probability: 25-35%, mostly priced in.
Technology Disruption (MODERATE, LOW-MODERATE)
See dedicated Disruptive Threat Assessment above. Sodium-ion and DLE are real but multi-year tail risks. Probability of material impact in 5-year window: low; in 10-year window: moderate.
Currency Translation (LOW-MODERATE, RECURRING)
CLP appreciation vs USD compresses cost-side margins. Sensitivity: ~150bps EBITDA margin per 10% CLP move. Recurring risk, partially hedged. Recent CLP rally to 850-900 from 1,000+ has pressured margins; further appreciation to 750-800 would compress 100-200bps.
Water Rights / Environmental (MODERATE, LOW)
Atacama brine extraction draws ~1,700 L/s of water from a hyper-arid environment. Environmental groups and indigenous (Atacameños) communities have raised concerns. Codelco JV partially addresses via shared monitoring, but production cap risk persists. Worst case: 10-20% volume cap, compressing 2027+ revenue by ~5-7%.
China Demand Slowdown (MODERATE, MODERATE)
China is ~40% of global lithium demand. EV credit/subsidy policy changes, real-estate-driven economic deceleration, or geopolitical disruption would slow demand growth. Sensitivity: 5% demand reduction = 8-10% EBITDA reduction at current price. Probability of material slowdown: 25-30%.
Tianqi Shareholder Overhang (LOW, LOW-MODERATE)
Tianqi (~22% holder) carries balance-sheet stress at the parent level (Tianqi Lithium debt restructuring 2020-2022). Forced sale risk is low currently but cannot be excluded if Chinese lithium downturn intensifies. A Tianqi block-sale would create temporary technical pressure; structural impact limited given 50% public float.
ESG Considerations
Environmental
Atacama brine evaporation is among the most water-intensive lithium production methods (~500,000 L water per ton LCE). Located in one of the driest regions on Earth (Atacama Desert), water rights are contested. SQM has reduced freshwater consumption ~30% since 2018 via brine recycling but absolute water consumption remains high. Carbon footprint is structurally low (solar evaporation, no mining/crushing) — SQM Atacama is in the lowest decile for lithium production carbon intensity (~3 tCO2e/t LCE vs hardrock ~12-15 tCO2e/t LCE).
Social / Indigenous Relations
Atacameños indigenous communities (Likanantai people) hold ancestral land claims overlapping the Salar de Atacama operation. ILO Convention 169 consultation requirements have been formally complied with but tensions persist. SQM has agreements with 18 Atacameño communities providing direct financial benefits ($10-15M/yr). The Codelco JV explicitly preserves these arrangements.
Governance
Governance is the primary ESG concern. Pampa Group (~25%) and Tianqi (~22%) co-control creates a complex dynamic with periodic minority shareholder concerns. Historical related-party concerns (2014-2018, including SVS investigations) were settled in 2019 but reputational drag persists. Board independence has improved (5 of 8 independent post-2020 reforms). The Codelco JV introduces state-owned enterprise governance adjacency post-2030, raising questions about independence and dividend policy continuity.
ESG ratings: MSCI rating BBB (average), Sustainalytics medium risk (24.5), ISS Quality 4. Below-peer governance scoring (driven by ownership concentration and historical related-party items) is partially offset by environmental scores benefiting from low-carbon brine extraction. For ESG-mandated investors, SQM is includable but at the watchlist margin — not a core ESG holding.
Climate & Transition Alignment
SQM's products are critical inputs to the energy transition: lithium for EVs and stationary storage, iodine for X-ray contrast (healthcare), SPN for sustainable agriculture, solar salts for CSP. Net-positive transition profile. Operationally, Atacama uses solar evaporation (zero combustion emissions in upstream lithium), and conversion plants are pursuing 2040 net-zero targets. Carbon footprint is among the lowest decile in lithium production. The transition story is genuine, but valuation already reflects it.
Conclusion
We initiate coverage of SQM with a SELL rating and a $57.00 12-month target price, implying (35.7%) downside from the current $88.70 close. Our target is the output of the DCF base case ($57.18 rounded down to $57.00 per coverage policy — no rounding up), at WACC 9.85% and exit EV/EBITDA 9.0x. The rating is determined by the valuation framework, not preselected: SELL applies because implied downside exceeds (5%) per our policy thresholds (BUY: >+15%; HOLD: -5% to +15%; SELL: <-5%).
Conviction is Moderate, not High. The Bull case ($88.90) approximates the current price — meaning the market is rational if all three supporting factors (faster lithium recovery, higher terminal multiples, accretive Codelco JV) converge. We assess the joint probability at 25-30%, well below the ~95-100% the market currently embeds. The asymmetry favors the SELL: limited upside (Bull case = current price), material downside (Base = $57, Bear = $29).
Key catalysts to watch: Q1 2026 earnings (May 2026) for lithium volume/price trajectory; Codelco JV formal agreement (expected Q3 2026); 2027 capex guidance update; lithium price S&D inflection signals from Australian lepidolite producer commentary and Chinese converter utilization data. A material deterioration in any of these triggers our Bear case ($28-29 fair value).
Probability-weighted target derivation: DCF base case $57.18, rounded to nearest $0.50 (NOT rounded up) = $57.00. Implied downside: (35.7%). Rating: SELL.
Catalysts (12-Month)
We map the 12-month catalyst calendar with explicit directional bias and magnitude. Most catalysts are skewed neutral-to-negative for the SELL thesis given how much positive outcome is already priced in. Asymmetry favors disappointments triggering downward revisions; positive surprises must clear an unusually high bar to drive incremental upside.
Date | Event | Bias | Magnitude | Key Watch |
May 2026 | Q1 2026 Earnings | Negative skew | High | Lithium volume/price; iodine pricing; SPN volumes; 2026 guide |
Jun 2026 | Codelco JV term sheet update | Mixed | Very High | Royalty structure, capex sharing, governance terms |
Aug 2026 | Q2 2026 Earnings | Negative skew | High | Mid-year lithium price trajectory; supply discipline signals |
Sep 2026 | Chile mining royalty bill vote | Negative | Medium | Final royalty rate; lithium-specific provisions |
Q3 2026 | Codelco JV formal agreement | Mixed | Very High | NPV uplift confirmation; downside if dilutive |
Nov 2026 | Q3 2026 Earnings | Negative skew | High | YTD margin trajectory; lithium price assumption update |
Q4 2026 | Mt. Holland Phase 1 commercial production | Positive | Medium | Volume contribution; cost positioning vs nameplate |
Mar 2027 | Q4 2026 Earnings & 2027 Guide | Mixed | Very High | Capex update, lithium price guide, dividend policy |
Target Price Derivation
Target price methodology: DCF base case primary, cross-checked against peer multiples and bridge-to-current-price analysis. Rating derived per pipeline rule:
- BUY: implied upside >+15% from current price
- HOLD: implied range -5% to +15%
- SELL: implied downside >-5%
DCF base case fair value: $57.18. Rounded down to nearest $0.50 per coverage policy (NO rounding up): $57.00 target. Implied upside / (downside): (35.7%). Rating: SELL.
Path to $57.00 — Re-rating Mechanism
The path from $88.70 to $57.00 over 12 months requires market repricing on three fronts: (1) terminal lithium price expectation reset from ~$18-19k/ton implied to $14-16k base — most likely catalyzed by Australian lepidolite restart commentary or Chinese converter utilization data; (2) terminal exit multiple compression from ~11x implied to 9x — driven by S&D rebalancing acknowledgment as 2026-2027 surplus persistence becomes visible; (3) Codelco JV NPV uplift consensus moderation as final terms reveal less accretion than peak optimism. None of these is binary; the re-rating may be gradual through 2026 earnings cycle rather than a single event.
Catalysts for downward revision: Q1-Q3 2026 earnings showing lithium volume/price below consensus; Codelco JV formal terms confirming royalty/operational dilution; mining royalty bill passing with lithium-specific surcharge; CLP further appreciation pressuring margins. Probability of at least one of these materializing within 12 months: 70%+.
Bear and Bull Path
Bear case ($28.95, -67% from current): triggered by lithium spot retesting $9-10k/ton on faster supply response or demand shock. Probability: 25-30%. Bull case ($88.90, ~flat from current): triggered by lithium spot at $18-20k/ton sustained AND Codelco JV upper-end NPV AND iodine prices >$60/kg AND no royalty changes. Probability: 20-25%. Probability-weighted central path lands close to base case ($57), supporting the SELL with Moderate conviction.
Disclaimer
This report was produced by an agentic AI workflow (Agentic Finance Chile) for research and educational purposes only. All financial data is sourced from public company filings (SQM 20-F annual reports, quarterly releases, NYSE filings), Bloomberg, FactSet consensus, and industry sources (Benchmark Mineral Intelligence, S&P Platts, Wood Mackenzie, BNEF) current to April 2026. Data may contain inaccuracies or errors introduced during automation.
The analysis reflects probabilistic views on lithium S&D dynamics, Codelco JV outcomes, and competitive positioning. Actual results may differ materially. The author holds no position in SQM, Albemarle (ALB), Arcadium (ALTM), Pilbara Minerals, Ganfeng Lithium, Tianqi Lithium, or any related security at time of publication. This is not investment advice. Readers should conduct their own due diligence and consult licensed financial advisors before making investment decisions.
Agentic Finance Chile — Apr 2026
Datos Estructurados
Fuente: Yahoo Finance, SEC EDGAR, Damodaran, Company Filings